Advancing, Bone

Advancing Bone Health: European Commission Approves Biocon Biologics' Denosumab Biosimilars

Published on 08/07/2025 at 18:07 | prnewswire.co.uk

Biocon Biologics Austria Belgium France Germany Italy Netherlands Spain Switzerland United Kingdom India

en | boerse | 67939400 |